Trends and projections of pancreatic cancer mortality in US adults by sex, race and ethnicity, region, and urbanization: a national analysis of CDC WONDER data, 1999–2050
This national analysis of CDC WONDER data from 1999 to 2025 reveals that pancreatic cancer mortality in U.S. adults has steadily increased and is projected to continue rising through 2050, with disproportionately higher burdens observed among men, older adults, non-Hispanic Black individuals, non-metropolitan populations, and the South, highlighting an urgent need for targeted early detection and equitable care strategies.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Pancreatic cancer is a particularly deadly disease because it often hides until it is too late. Unlike some cancers that cause noticeable symptoms early on, this one grows quietly inside the body, usually without pain or warning signs until it has spread. Because it is so difficult to catch early, and because it resists many standard treatments, it kills a large number of people relative to how many are diagnosed. In the United States, it has become the third most common cause of cancer death. The future of this disease depends on many factors, including how the population ages, changes in lifestyle habits like smoking and diet, and whether people can get timely medical care. Understanding where and how these deaths are happening is essential for doctors and policymakers who need to prepare hospitals, plan screening programs, and decide where to send resources to save lives.
A new national study has mapped out exactly how pancreatic cancer deaths have changed over the last quarter-century and looked ahead to see what might happen in the coming decades. Researchers examined records from the Centers for Disease Control and Prevention, looking at death certificates for adults over the age of twenty-five from 1999 through 2025. They counted every death where pancreatic cancer was listed as a cause, whether it was the main reason for death or a contributing factor. By analyzing these numbers across different groups of people—men and women, different racial and ethnic backgrounds, people living in cities versus rural areas, and residents of different parts of the country—the team built a clear picture of who is most at risk. They then used computer models to project these trends forward to the year 2050, creating a forecast that helps visualize the future burden of the disease.
The study found that the number of people dying from pancreatic cancer has been slowly but steadily rising. In 1999, the rate of death was about 17 per 100,000 people. By 2025, that number had climbed to roughly 19 per 100,000. The researchers predict this upward trend will continue, with the rate expected to reach nearly 21 per 100,000 by 2050. While this increase in the rate might seem small, the actual number of deaths is growing much faster because the total population is getting older and larger. In 1999, there were about 30,000 pancreatic cancer deaths in the United States; by 2025, that number had jumped to more than 55,000. The models suggest that without major changes in prevention or treatment, this number will keep climbing as the population ages.
Not everyone faces the same risk. The data shows a clear divide based on gender, with men dying from this disease at higher rates than women throughout the entire study period. Age is an even stronger factor; the vast majority of deaths occur in people over the age of sixty-five. In fact, the death rate for this older group is projected to rise sharply, reaching over 100 deaths per 100,000 people by 2050. Racial and ethnic disparities are also stark. Non-Hispanic Black adults have consistently had the highest death rates of any group. While the study suggests their rate might level off or dip slightly in the future, they will likely remain the group most affected by the disease. Non-Hispanic White adults, who make up the largest portion of the population, are also seeing their death rates rise significantly.
Where a person lives also matters. The study revealed that people living in rural, non-metropolitan areas are facing a growing challenge. While city dwellers have seen a slow increase in death rates, the rate in rural areas has been climbing faster and is projected to be higher by 2050. This gap likely reflects differences in access to specialized medical care, as pancreatic cancer often requires complex surgery and treatment that are only available at major hospitals in large cities. Regionally, the South is expected to see the steepest rise in deaths, potentially surpassing other parts of the country to have the highest death rate by mid-century. This shift suggests that the burden of the disease is moving, and health systems in the South will need to prepare for a heavier load.
The researchers also looked at where these deaths occur, finding that nearly half of all people with pancreatic cancer die at home. This is a significant shift that reflects both patient preferences and the availability of hospice care, but it also highlights that many patients are not spending their final days in a hospital setting. The study does not claim to have solved the mystery of why these trends are happening, but it does rule out the idea that the problem is going away on its own. The models are based on historical patterns, and while they cannot predict sudden breakthroughs in medicine or changes in policy, they provide a reliable warning based on current data. The authors emphasize that these projections are not set in stone; they are conditional on the assumption that current trends in risk factors and healthcare access continue.
Ultimately, this work serves as a roadmap for the future. It tells us that pancreatic cancer will remain a major public health challenge for decades to come. The rising numbers, particularly among older adults, men, Black communities, and rural populations, indicate that current efforts are not enough to stop the tide. The findings point to a need for better early detection methods for high-risk groups, more equitable access to specialized cancer centers, and a stronger focus on palliative care to support patients and their families. By understanding exactly who is most vulnerable and where the problem is growing, communities can begin to plan for a future where these deaths might be prevented or better managed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.